The US represents a major contributor to the North American pharmaceutical excipients landscape and is projected to expand steadily during the forecast period. According to The Insight Partners, the US Pharmaceutical Excipients Market is projected to register a CAGR of 5.9% during the forecast period. Growth is supported by the country's large pharmaceutical industry, increasing development of biologics and biosimilars, and continued demand for advanced drug delivery technologies.

According to The Insight Partners, the Pharmaceutical Excipients Market size is projected to reach US$ 17.60 billion by 2034 from US$ 10.03 billion in 2025. The market is expected to register a CAGR of 6.5% during 2026–2034. This growth is driven by rising pharmaceutical production, increasing demand for generic medications, advances in drug formulation technologies, and the growing use of biologics and biosimilars.

 Excipients play a critical role in formulation performance by providing functions such as binding, coating, controlled release, stabilization, viscosity modification, emulsification, and preservation. The increasing focus on patient-centric formulations and innovative drug delivery systems is expected to further expand opportunities for specialized excipient technologies.

Download Sample PDF - https://www.theinsightpartners.com/sample/TIPRE00003534

Pharmaceutical Excipients Market Drivers and Opportunities

Several factors are shaping the long-term growth trajectory of the Pharmaceutical Excipients Market. The increasing production of generic medicines is a major growth driver because manufacturers require high-quality excipients to achieve consistent formulation performance. The growing development of biologics and biosimilars is also generating demand for specialized excipients that can improve protein stability and support sophisticated injectable formulations. In parallel, pharmaceutical companies are investing in novel excipients to address challenges related to drug solubility, bioavailability, stability, and targeted delivery.

Sustainability is emerging as another important trend. Manufacturers are increasingly exploring plant-derived, biodegradable, and environmentally responsible excipients as pharmaceutical companies strengthen their sustainability initiatives. Patient-centric drug development is also encouraging the development of excipients that support convenient dosage forms, improved taste, controlled release, and enhanced therapeutic performance. Emerging economies provide additional opportunities because expanding pharmaceutical manufacturing capabilities and healthcare infrastructure are increasing demand for cost-effective and high-quality excipient materials.

Pharmaceutical Excipients Market Size, Share, Trends, Analysis, and Forecast by 2034

• Market Size, 2025: US$ 10.03 Billion
• Market Size, 2034: US$ 17.60 Billion
• CAGR, 2026–2034: 6.5%
• North America: Dominated the market in 2025.
• US Growth: Expected to register a 5.9% CAGR during the forecast period.
• Fastest-Growing Region: Asia Pacific is expected to record strong growth, supported by expanding pharmaceutical manufacturing and demand for generics and biosimilars.
• Major Application: Oral formulations represented a leading application area historically.
• Key Functionality Trend: Suspending and viscosity agents are anticipated to witness rapid growth.
• Key Product Trend: Organic chemicals have represented a significant product category.

Market Segmentation Analysis

The Pharmaceutical Excipients Market is segmented by type, clinical indication, functionality, application, end user, and geography. By type, the market includes bioresorbable polymers and lipid/liposome-based formulations, oleochemicals, sugars, cellulose, starches, petrochemicals, plant proteins, polyols and cyclodextrins, inorganic chemicals, and other types. By clinical indication, segmentation covers cancer, metabolic, infectious disease, dental, ophthalmic, cardiovascular, and other indications.

Based on functionality, the market includes coloring and coating agents; sweetener and flavoring agents; suspending and viscosity agents; preservatives and controlled-release agents; antioxidants and oils; tablet fillers and diluents; binders, compression, and granulating agents; emulsifiers; surfactants; and other functionalities. By application, the market is categorized into oral, injectable, topical, and other applications. End users include pharmaceutical industries, biopharmaceutical industries, animal health, and other users.

Regional Analysis

North America held a significant position in the global Pharmaceutical Excipients Market in 2025, supported by advanced pharmaceutical infrastructure, high research activity, and strong demand for biologics and innovative therapies. Europe maintains substantial market opportunities due to stringent regulatory standards, generic drug production, and growing interest in sustainable excipients. Asia Pacific is anticipated to be the fastest-growing region during the forecast period, driven by expanding pharmaceutical manufacturing hubs, cost advantages, healthcare infrastructure development, and rising production of generic and biosimilar medicines. South and Central America are benefiting from increasing pharmaceutical manufacturing and healthcare investments, while the Middle East and Africa present emerging opportunities associated with healthcare infrastructure development and pharmaceutical localization.

Top Players in the Pharmaceutical Excipients Market

Key players are focusing on product innovation, regulatory compliance, strategic partnerships, capacity expansion, and development of advanced excipient technologies to strengthen their competitive positions.

• BASF SE
• JRS PHARMA GmbH & Co KG
• Roquette Freres SA
• Avantor Inc
• Archer-Daniels-Midland Co
• Evonik Industries AG
• The Dow Chemical Co
• The Lubrizol Corp
• Ashland Inc
• MEGGLE GmbH & Co KG

Recent developments demonstrate the industry's emphasis on innovative excipients. In October 2025, Roquette launched KLEPTOSE Crysmeb methyl-beta-cyclodextrin to support improved solubility and stability of active biopharmaceutical ingredients. In September 2025, Evonik launched MaxiPure Polysorbate 80, a high-purity surfactant designed for injectable and biopharmaceutical applications.

Market Trends and Growth Analysis

The Pharmaceutical Excipients Market is moving toward multifunctional, high-performance, sustainable, and application-specific excipients. The growing complexity of pharmaceutical formulations is increasing the need for materials that can simultaneously improve stability, solubility, manufacturability, and drug delivery performance. Continuous manufacturing and personalized medicine are expected to create additional demand for flexible excipient solutions. Furthermore, the increasing use of advanced drug delivery systems and biologics will encourage excipient manufacturers to develop technologies tailored to complex pharmaceutical formulations.

About Us

The Insight Partners is an one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.

Contact Us

Ankit Mathur | The Insight Partners

E-mail: ankit.mathur@theinsightpartners.com
Phone: +1-646-491-9876

Also Available in : Korean | German | Japanese | French | Chinese | Italian | Spanish